Literature DB >> 3921231

Production of multiple cytokines by clones of human large granular lymphocytes.

P Allavena, G Scala, J Y Djeu, A D Procopio, J J Oppenheim, R B Herberman, J R Ortaldo.   

Abstract

LGL in addition to mediating natural killer (NK) activity, can secrete a variety of lymphokines, depending on the stimulus used: interleukin-1 (IL-1), interleukin-2 (IL-2), interferon alpha and gamma (IFN), and B-cell growth factor (BCGF). To define more directly whether cells with NK activity can also secrete one or more cytokines, we obtained clones by limiting dilution assays from highly purified preparations of human LGL and cultured them in IL-2-containing medium for several weeks. All the clones tested spontaneously produced detectable levels of IFN-gamma and 35 of 40 clones (87%) produced higher levels when stimulated with PHA. A smaller proportion (16%) of clones (9 of 54) secreted IL-1 after stimulation with LPS, while 34% of the clones (17 of 49) produced IL-2 in response to PHA stimulation. Cytokine production was associated with both cytotoxic and noncytotoxic clones and did not correlate with their surface phenotype, as has been observed for fresh LGL. The ability to produce IL-1 or IL-2 was not usually found within the same clones following PHA and LPS stimulation, respectively; however two clones produced both IL-1 and IL-2 when stimulated in different experiments, but not at the same time. In addition, two of nine cloned LGL simultaneously produced IFN gamma and IL-1. These results indicate that LGL-derived clones have the ability to produce multiple cytokines, suggesting that the LGL population may play an important immunoregulatory role and may also be capable of self-regulation of cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921231     DOI: 10.1007/bf00199719

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  32 in total

1.  Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation.

Authors:  S Arai; H Yamamoto; K Itoh; K Kumagai
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

2.  The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.

Authors:  R A Dempsey; C A Dinarello; J W Mier; L J Rosenwasser; M Allegretta; T E Brown; D R Parkinson
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

3.  Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.

Authors:  K Handa; R Suzuki; H Matsui; Y Shimizu; K Kumagai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.

Authors:  B M Stadler; E H Berenstein; R P Siraganian; J J Oppenheim
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

Authors:  H Rabin; R F Hopkins; F W Ruscetti; R H Neubauer; R L Brown; T G Kawakami
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Interleukin 2 dependence of human natural killer (NK) cell activity.

Authors:  W Domzig; B M Stadler; R B Herberman
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Phenotypic diversity within clones of human normal T cells.

Authors:  D Zagury; J Bernard; D A Morgan; M Fouchard; M Feldman
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

8.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  14 in total

1.  Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells.

Authors:  S E Christmas; A Meager; M Moore
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

2.  Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.

Authors:  A Jewett; X H Gan; L T Lebow; B Bonavida
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 4.  The human NK cell--a short over-view and an hypothesis on NK recognition.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Modification of regression of virally xenogenized tumor cells by cyclophosphamide and busulfan.

Authors:  K Morikawa; J Hamada; T Itaya; M Ishikawa; N Takeichi; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.

Authors:  A S Chong; A Aleksijevic; P Scuderi; E M Hersh; W J Grimes
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  CD8+ cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats.

Authors:  M N Sato; E H Yamashiro-Kanashiro; M M Tanji; R Kaneno; M L Higuchi; A J Duarte
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 8.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.

Authors:  J D Gray; A Lash; A C Bakke; R C Kitridou; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

10.  Purification and characterization of the human interferon-gamma receptor from placenta.

Authors:  J Calderon; K C Sheehan; C Chance; M L Thomas; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.